Journal of the Neurological Sciences
Volume 292, Issue 1 , Pages 114-116 , 15 May 2010

Guillain-Barré Syndrome as leading manifestation of Graft-versus-Host Disease in an allogeneic bone marrow transplanted patient

Received 29 September 2009 ,Revised 13 January 2010 ,Accepted 21 January 2010.

References 

  1. Van Doorn PA, Ruts L, Jacobs B. Clinical features, pathogenesis, and treatment of Guillain-Barré Syndrome. Lancet Neurol. 2009;8:158–164
  2. Hughes RAC, Cornblath DR. Guillain-Barré Syndrome. Lancet. 2005;366:1653–1666
  3. Sostak P, Padovan CS, Yousry TA, Ledderose G, Kolb HJ, Straube A. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology. 2003;60:842–848
  4. Wen PY, Alyea EP, Simon D, Herbst RS, Soiffer RJ, Antin JH. Guillain-Barré syndrome following allogeneic bone marrow transplantation. Neurology. 1997;49:1711–1714
  5. Nasilowska-Adamska B, Lysiak Z, Halaburda K, Szczepinski A, Ejduk A, Marianska B. Guillain-Barré Syndrome — pathological connection with GvHD after allogeneic bone marrow transplantation. Ann Transplant. 2006;11:24–25
  6. Couriel D, Caldera H, Champlin R, Komanduri K. Acute Graft-versus-Host Disease: pathophysiology, clinical manifestations, and management. Cancer. 2004;101:1936–1946
  7. Baird K, Pavletic SZ. Chronic graft versus host disease. Curr Opin Hematol. 2006;13:426435
  8. Faulds D, Goa KL, Benfield P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs. 1993;45:953–1040
  9. Zettl UK, Gold R, Toyka KV, Hartung HP. Intravenous glucocorticosteroid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat. J Neuropathol Exp Neurol. 1995;54:540–547

PII: S0022-510X(10)00047-X

doi: 10.1016/j.jns.2010.01.020

Journal of the Neurological Sciences
Volume 292, Issue 1 , Pages 114-116 , 15 May 2010

Article Tools